Aortic graft infection (AGI) poses a serious clinical problem in vascular surgery. An important dilemma in clinically suspected AGI is confirmation of definite proof of the graft infection. Positive cultures from a percutaneous aspirated perigraft abscess or from surgically obtained material are considered by many the gold standard for diagnosing AGI. [1] [2] [3] [4] [5] However, a perigraft abscess is not always present and, even if present, may not always be suitable for puncture. Also, a patient with AGI is often critically ill and not able to tolerate a diagnostic surgical procedure. Imaging, therefore, may play an important role in increasing the likelihood of the diagnosis of AGI.
Several case series have suggested a promising role of 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) scanning to this respect. 6-11 18 F-FDG PET has been reported to have a high sensitivity (up to 91%) but low specificity (up to 64%) and therefore is potentially suitable for diagnosing the presence of AGI. 7 18 F-FDG PET scans are assessed using the quantitative maximal standardized uptake value (SUVmax) and tissue-to-background ratio (TBR) as well as the visual parameters of 18 F-FDG distribution patterns and the visual grading scale (VGS).
There is no consensus with respect to the interpretation of the 18 F-FDG-PET findings in the reviewed studies in which a VGS was used. Only intense focal 18 F-FDG uptake has been claimed to be a significant predictor for the presence of infection, but the role of the other parameters has not been established. 10, 12 More recently, a semiquantitative method was suggested for the evaluation of thoracic prosthetic graft infections in a small group in which an SUVmax >8 in the perigraft area was considered the cutoff value for distinguishing between an infected graft and a noninfected graft. 13 Ideally, one would study a large group of patients with symptoms suggestive of AGI in whom the diagnostic procedures of interest and the current gold standard have been performed. 14 The aim of the present study was to assess the performance of the 18 F-FDG PET scanderived SUVmax, TBR, FDG distribution pattern, and VGS in the diagnosis of AGI in patients with suspected AGI.
METHODS
Patients with a central aortic prosthetic graft were identified from a prospectively maintained database at the University Medical Center Utrecht between January 2006 and June 2013. Medical records of all patients in the database were analyzed to identify those with a central aortic prosthetic graft in whom an AGI was clinically suspected. Clinical symptoms suggestive of AGI included undefined fever, a deep wound infection, an incision fistula, persisting high laboratory infection parameters after central prosthetic vascular surgery, or a combination of these factors. The present study included all patients with a suspected AGI who underwent 18 F-FDG PET with computed tomography angiography (CTA) in the diagnostic workup and in whom periprosthetic samples for microbiologic culturing were obtained during the diagnostic workup or during surgery (removal of the graft).
Basic patient characteristics and information about the initial operation, type of graft material, laboratory parameters, and clinical symptoms at the time of the 18 F-FDG PET scan and definite treatment were collected from the medical records. Comorbidities were defined as recommended by the Ad Hoc Committee on Reporting Standards. 15 Retrospective "patient's files" research is not in scope of the Dutch WMO (Wet Mensgebonden Onderzoek: Law human bound research) and Investigational Review Board approval was therefore not required. As a consequence, patient informed consent was not obtained. Patients' data were analyzed anonymously.
Definitive proof of infection. AGI was considered proven only in case of a positive culture of material obtained by puncture or after surgery. 18 F-FDG PET analysis. Patients were instructed to fast, except for glucose-free oral hydration, for 6 hours before the 18 F-FDG injection based on their weight (2-3.7 MBq/kg). Blood glucose levels were measured before injection. Diabetic patients were instructed to keep to their regular schedule of glucose-controlling drugs. With each 18 F-FDG PET, whole-body mode (ie, from halfway up the thigh to the crown of the head) studies were used on a Phillips Allegro PET scanner (Philips Medical Systems, Bothell, Wash) and a Biograph mCT scanner (Siemens Medical Systems, Knoxville, Tenn). Approximately 60 minutes p.i. 18 F-FDG, PET emission data were acquired from total body, 5 minutes per bed position. The measured resolution is 2 to 4 mm in full width at half maximum transaxially in the center of the field of view. For PET data reconstruction, 3 interactions, 21 subsets, with an image size of 256 Â 256, zoom 1, was used.
Two experienced nuclear medicine physicians (B.K., R.S.) assessed the 18 F-FDG PET images, blinded for the clinical and the CTA scan data. The following features were used to further analyze and quantify the images: SUVmax, TBR, 18 F-FDG distribution pattern, and VGS. A region of interest was drawn around the area of the vascular prosthesis with suspicion of infection to calculate the SUVmax. This was performed in three dimensions (sagittal, coronal, and transaxial). SUVmax was calculated corresponding to the voxels with the highest 18 F-FDG uptake. TBR was defined as SUVmax divided by SUVmax of the caval vein (blood pool). The 18 F-FDG distribution pattern was classified as focal or diffuse. The VGS was used to classify the probability of AGI on 18 F-FDG PET scanning as low (VGS 0, I, or II) or high (VGS III or IV).
The intensity of 18 F-FDG uptake was graded on a 5-point scale as: d Grade 0, 18 F-FDG uptake similar to that in the background; d Grade I, low 18 F-FDG uptake, comparable with that by inactive muscles and fat; d Grade II moderate 18 F-FDG uptake, clearly visible and higher than the uptake by inactive muscles and fat; d Grade III, strong 18 F-FDG uptake, but distinctly less than the physiologic urinary uptake by the bladder; and d Grade IV, very strong 18 F-FDG uptake, comparable with the physiologic urinary uptake by the bladder. 7 CTA analysis. CTA imaging was performed, after administration of intravenous contrast, by Multidetector CT Siemens Somatom Definition (Siemens AG Medical Solutions, Forchheim, Germany). CTA scans were assessed on a digital workstation by a radiologist who was blinded for clinical and 18 F-FDG-PET data. Current literature regards the following items as predictive for vascular prosthetic graft infection on CTA scanning: the presence of aortoenteric fistula, pseudoaneurysm, intergraft thrombus, hydronephrosis, perigraft fluid (Hounsfield units [HU]), perigraft air, perigraft soft tissue attenuation (HU), focal bowel wall thickening (mm), discontinuity of the aneurysmal wrap (mm), maximal diameter of the largest air bubble, maximal diameter of the fluid collection (mm), and visual judgment by a radiologist. 6 Scoring these items was complemented by a visual judgment for the likelihood of AGI. The likelihood of AGI was classified as low or high, based on a visual scale judgement from 10 to 100 points. A low probability was defined from 10 to 54 points and a high probability from 55 to 100 points.
Statistical analysis. Baseline characteristics are presented as mean 6 standard deviation or percentages. The diagnostic value of 18 F-FDG PET for detecting AGI was assessed for the following 18 F-FDG PET outcomes: SUVmax, TBR, 18 F-FDG distribution pattern, and VGS. Furthermore, to measure the ability of these parameters in predicting presence of AGI, a receiver operating characteristic curve (ROC) was plotted and area under the ROC curve (AUC) with 95% confidence interval (CI) was calculated. The diagnostic ability was classified by the AUC values as follows: 0.5 to 0.6 failed, 0.6 to 0.7 poor, 0.7 to 0.8 fair, and 0.8 to 1.0 good. Cutoff points with the highest sensitivity and specificity from the AUC curves were used to determine a threshold value for TBR and SUVmax. Next, as for the VGS, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated.
The diagnostic value of CTA for detecting AGI was assessed for the CTA characteristics of aortoenteric fistula, pseudoaneurysm, intergraft thrombus, hydronephrosis, perigraft fluid, perigraft air, perigraft soft tissue, focal bowel wall thickening and discontinuity of the aneurysmal wrap. For these CTA characteristics sensitivity, specificity, PPV, and NPV were calculated. Data were collected and processed using the IBM SPSS 20.0 software (IBM Corp, Armonk, NY).
RESULTS
Patient selection. We identified 37 patients who met the inclusion criteria. Specimens for microbiologic analysis were obtained in eight patients through percutaneous puncture and in 29 patients through surgery. Positive cultures were found in 21 patients during surgery (n ¼ 15) or puncture (n ¼ 6). The Fig shows the pathways for including patients with a suspected AGI.
Baseline patient characteristics. The 37 patients (73% male) were a mean age of 66 6 8.0 years (range, 50-86 years) at the time the 18 F-FDG PET examination took place. All implants were prosthetic grafts and implanted in the thoracoabdominal-iliac tract. Mean duration from graft implantation until 18 F-FDG PET scanning was 5.3 6 6.0 years (range, 0.05-18.31 years). Antibiotic treatment was initialized before surgical treatment in 89% of the patients. Of those patients with a positive culture, 20 (95%) received preoperative antibiotics compared with 13 of the patients (81%) with a negative culture result. Patient characteristics are described in Table I . The initial treatment in 23 patients (62%) was because of aneurysmatic disease. Operative details are listed in Table II . An AGI was proven in 21 of 37 patients, yielding a prior probability for the presence of AGI of 57%. SUVmax value. Mean SUVmax for proven infections was 8.1 6 3.7 (range, 3.6-18.5) compared with 5.0 6 2.3 (range, 2.7-11.0) for the other group (Table III) . The AUC of SUVmax was classified as fair, with a value of 0.78 (95% CI, 0.63-0.93). Sensitivity, specificity, PPV, and NPV, were calculated for SUVmax cutoff values of 4, 6, 8, and 10 (Table IV) . When the cutoff point was set at a value $8 to indicate a positive test, the PPV was 80% and the NPV was 54%.
TBR. The mean TBR was 5.9 6 2.7 (range, 1.7-13.0) for proven infections compared with 4.1 6 2.1 (range, 1.7-8.5; Table III ). The ability of TBR in predicting the presence of AGI was classified as fair, with an AUC of 0.70 (95% CI, 0.52-0.87). Sensitivity, specificity, PPV, and NPV were calculated for TBR cutoff values of 2, 4, 6, and 8 (Table V) . When we put the cut point at the value $6 to indicate a positive test, the PPV was 73% and the NPV was 52%.
Visual 18 F-FDG-PET interpretation. The VGS showed suspicion for AGI was high in 24 patients (65%). AGI was eventually proven in 18 of these 24 patients (75%), leading to a PPV of 75%. The 18 F-FDG PET scan in 13 patients (35%) was judged as having a low suspicion for AGI. Ten of these cases were finally proven negative for AGI based on culture material, yielding a NPV of 77%. The use of these parameters yielded a PPV of 61% and a NPV of 67 % (Table VI) . These estimates did not differ from the prior probability in the study population.
The interobserver agreements were calculated between the two nuclear medicine physicians and were excellent. The average ratings and standard deviations were quite equal, and the correlations among the ratings of SUVmax, TBR, and VGS of the two ratings were 0.89, 0.80, and 0.74, respectively. The interobserver agreement regarding the likelihood for AGI was 0.49 (fair).
CTA characteristics. On the basis of the CTA analysis, all of the 37 patients (100%) were judged positive for AGI. In 21 of these patients, AGI was eventually proven by positive cultures, yielding a PPV of 57%. The sensitivity, specificity, PPV, and NPV, of the various CT parameters are reported in Table VII .
DISCUSSION
This study is among the first to report the use of (semi) quantitative (SUVmax and TBR) and qualitative (distribution patterns and VGS) parameters in the diagnostic workup of patients with suspected AGI. The ability of these four parameters to yield a definite proof of AGI is modest.
The typical patient with AGI is fragile and with various comorbidities. A reliable imaging tool is essential for the diagnosis of AGI. A false-negative test result may refrain the patient from proper antibiotic or surgical treatment and may negatively affect the prognosis. A false-positive test result may result in unneeded extensive surgical procedures. 16 Reports on the use of 18 F-FDG PET in AGI are limited. These reports seem to indicate that 18 F-FDG PET scanning has a better diagnostic accuracy than CTA for the detection of AGI and may very well prove to be the new gold standard for minimal invasive AGI diagnosis. [6] [7] [8] [9] [10] However, most evidence comes from case series rather than cohort studies. Focal uptake intensity compared with a diffuse or linear 18 F-FDG distribution along the graft was studied earlier and was associated with a vascular graft infection with a PPV of 91% and a NPV of 95%. 7 In this study, we could not confirm these high predictive values. The main difference between the studies is that we included only patients in whom AGI was proven through cultures, whereas Spacek et al 10 also included clinically proven AGI, increasing the prevalence of AGI and with that potentially the PPV.
The intensity of 18 F-FDG uptake is most commonly assessed using a grading scale of 1 to 5 points. This grading scale is analogous to the VGS of Deauville, originally developed for the interpretation of 18 F-FDG PET scans made for lymphomas, 12 and to the scale of 0 to 4 points of Stumpe et al, 17 used for the detection of orthopedic infections. Because both scales only address the uptake intensity, they are unable to firmly differentiate between infection and inflammation. PPV and NPV of an 18 F-FDG PET scan using only increased uptake as a marker for graft infection have been reported to be 56% and 93%, respectively. 7 In our study, the prior probability for the presence of AGI was 57%. Adding VGS information resulted in a PPV up to 75%. Therefore, the VGS may be of use in the assessment of presence of AGI in patients with suspected AGI. However, confirmation in larger studies is needed.
SUVmax measurements are known to be influenced by many different factors of a technical and biologic nature and are difficult to compare across hospitals. 18 Only one small case series (n ¼ 8) reported the use of SUVmax in the diagnosis of AGI. A cutoff value of >8 showed a sensitivity of 100% and specificity of 80% whether or not an aortic graft was infected. 13 TBR seems to be more reproducible then the SUV. 19 We found TBR was fairly accurate in diagnosing AGI, with an AUC of 0.70; yet, a clinician uses cutoff values rather than AUC. The use of cutoff values, however, leads to a debate regarding overdiagnosis and underdiagnosis and its consequences. In AGI, we assume a high PPV is preferable to a NPV, therefore needing a relatively high value of SUVmax or TBR.
CTA is still considered the gold standard for diagnosing AGI. 4, 7, 20 The amount of false-negative CTA results, however, is considerably high, especially in the presence of low-grade infections. Overall specificity has been reported up to 100% and an overall sensitivity of 56%. 19 In our study, we were unable to confirm these results. The specificity of the various CT parameters ranged between 7% and 100%, the sensitivity ranged between Grade 0, 18 F-FDG uptake similar to that in the background; grade I, low FDG uptake, comparable with that by inactive muscles and fat; grade II, moderate FDG uptake, clearly visible and higher than the uptake by inactive muscles and fat; grade III, strong FDG uptake, but distinctly less than the physiologic urinary uptake by the bladder; grade IV, strong FDG uptake, comparable with the physiologic urinary uptake by the bladder. Grade 0, I, and II are considered low probability for AGI; grade III and IV are considered high probability for AGI. 10% and 100%, PPV ranged between 30% and 100%, and NPV ranged between 32% and 100% (Table VII) . Some aspects of the study need to be addressed. Ideally in a diagnostic study, all patients are enrolled who are suspected to have the studied disease and undergo all of the diagnostic tests that are being investigated, together with a gold standard to assess the final diagnosis. Clearly, that is difficult in studies of AGI. Not all diagnostic tests are uniformly performed, and the gold standard cannot be obtained in all patients for several reasons. That diagnostic studies in AGI may yield biased results (underestimating or overestimating the accuracy) is therefore inevitable. The extent to which bias occurred in our study is difficult to estimate. Furthermore, the difference in positive and negative cultures might be due to the use of antibiotic therapy in patients when AGI is suspected. Antibiotic therapy was started in 89% of the patients and might have yielded false-negative cultures. Routine microbiologic techniques can sometimes be insufficient in isolating the microorganism from perigraft material. 21, 22 Use of sonication techniques have been described to identify indolent gram-positive microorganims. 21, 22 However, these sonication techniques were not applied in this retrospective study because they were not available in our hospital.
We restricted the present study to only those patients with all information available. However, this does not reflect current clinical practice because AGI may also be based on clinical symptoms and imaging only, irrespective of the culturing results. Therefore, our diagnostic test results may be an overestimation of what is found in real clinical life. Furthermore, this resulted in the loss of several patients during the process for which information was lacking. Whether this is selective loss (ie, different among those with and without AGI and different among those with and without clear imaging results) is unknown to us.
This study should also be conducted prospectively to prevent these kinds of limitations. Our study reflects the difficulties with performing diagnostic studies in patients with a rare but severe disease in whom the assessment of a diagnosis is difficult to establish. As such, we call for a well-developed protocol and (inter-) national collaboration to set up future diagnostic studies on AGI.
CONCLUSIONS
Our study, performed in a small sample of patients suspected of AGI, showed that the diagnostic ability of 18 F-FDG parameters and VGS is modest.
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